tovorafenib,day101
day one biopharmaceutical
['tovorafenib', 'firefly-1', 'dayone']
icymi - firefly-1 as presented at #asco23: 67% orr + 93% cbr in 69 heavily pre-tx rano-hgg evaluable pts of durable tumor reduction w/ tovorafenib monotx in heavily pre-tx pts rolling submission of nda to fda started by ; expected done 10/23 #btsm #plgg 
#Cancer #Pharmacist (#OncoPharm) | #ChildhoodCancer #Advocate | Michigan ‘96 - #GoBlue | Tweets are not medical advice | Interests 🐶🏈⚾️🏒🥍🏉✈️⛰🥃🍽🧩📚